Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.74
+0.58 (1.26%)
At close: Mar 9, 2026, 4:00 PM EDT
46.28
-0.46 (-0.98%)
After-hours: Mar 9, 2026, 5:20 PM EDT
KNSA Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,577 | 3,127 | 1,428 | 1,234 | 1,042 | 811 | |
| Market Cap Growth | 151.63% | 118.92% | 15.76% | 18.45% | 28.46% | -32.59% | |
| Enterprise Value | 3,173 | 2,784 | 1,215 | 1,046 | 848 | 617 | |
| Last Close Price | 46.74 | 41.25 | 19.78 | 17.54 | 14.98 | 11.77 | |
| PE Ratio | 62.32 | 52.99 | - | 87.60 | 5.68 | - | |
| Forward PE | 36.35 | 27.32 | 42.93 | - | - | - | |
| PS Ratio | 5.28 | 4.61 | 3.37 | 4.57 | 4.73 | 21.04 | |
| PB Ratio | 6.28 | 5.51 | 3.26 | 2.81 | 2.63 | 4.38 | |
| P/TBV Ratio | 6.48 | 5.66 | 3.38 | 2.93 | 2.76 | 4.89 | |
| P/FCF Ratio | 26.22 | 22.92 | 56.20 | 93.67 | 182.67 | - | |
| P/OCF Ratio | 25.93 | 22.66 | 55.59 | 92.76 | 179.37 | - | |
| EV/Sales Ratio | 4.68 | 4.11 | 2.87 | 3.87 | 3.85 | 16.02 | |
| EV/EBITDA Ratio | 40.28 | 35.34 | - | - | 69.62 | - | |
| EV/EBIT Ratio | 41.09 | 36.06 | - | - | 86.73 | - | |
| EV/FCF Ratio | 23.26 | 20.41 | 47.81 | 79.39 | 148.64 | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | |
| Debt / EBITDA Ratio | 0.11 | 0.11 | - | - | 0.38 | - | |
| Debt / FCF Ratio | 0.07 | 0.07 | 0.39 | 0.93 | 1.04 | - | |
| Net Debt / Equity Ratio | -0.71 | -0.71 | -0.53 | -0.44 | -0.47 | -0.95 | |
| Net Debt / EBITDA Ratio | -5.14 | -5.14 | 5.32 | 8.49 | -15.17 | 1.14 | |
| Net Debt / FCF Ratio | -2.97 | -2.97 | -9.20 | -14.74 | -32.39 | 1.39 | |
| Asset Turnover | 1.01 | 1.01 | 0.77 | 0.55 | 0.64 | 0.13 | |
| Inventory Turnover | 7.56 | 7.56 | 6.58 | 3.41 | 3.72 | - | |
| Quick Ratio | 3.09 | 3.09 | 2.84 | 3.58 | 4.48 | 4.15 | |
| Current Ratio | 3.79 | 3.79 | 3.30 | 4.34 | 5.16 | 4.38 | |
| Return on Equity (ROE) | 11.73% | 11.73% | -9.85% | 3.37% | 63.10% | -63.55% | |
| Return on Assets (ROA) | 7.18% | 7.18% | -5.15% | -3.19% | 1.76% | -33.63% | |
| Return on Invested Capital (ROIC) | 28.80% | 27.89% | -20.30% | -11.05% | 8.87% | -7244.96% | |
| Return on Capital Employed (ROCE) | 12.40% | 12.40% | -9.50% | -5.40% | 2.40% | -83.30% | |
| Earnings Yield | 1.65% | 1.89% | -3.02% | 1.14% | 17.60% | -19.48% | |
| FCF Yield | 3.81% | 4.36% | 1.78% | 1.07% | 0.55% | -15.63% | |
| Buyback Yield / Dilution | -10.58% | -10.58% | 0.69% | -2.13% | -2.69% | -10.89% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.